ACBM
What one share of Acro Biomedical Co. holds
Services – Amusement and Recreation Services
Since January 30, 2017, following a change of control, our business has been the development and marketing nutritional products that promote wellness and a healthy lifestyle. Our revenue to date has resulted from the purchase of products from three suppliers in the Republic of China (Taiwan), one of which accounted for all of our purchases in the year ended December 31, 2022.
Acro Biomedical Co.’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.00 |
|---|---|
| Profit | −$0.00 |
| Cash and investments | $0.00 |
| Book value | −$0.01 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2017 | $0.01 | $0.00 | — | −$0.01 | — | $0.01 |
| 2018 | $0.17 | $0.01 | — | −$0.00 | — | $0.03 |
| 2019 | $0.03 | −$0.01 | — | $0.00 | — | $0.02 |
| 2019 | $0.00 | −$0.01 | — | −$0.00 | — | $0.02 |
| 2020 | $0.01 | −$0.00 | — | −$0.00 | — | $0.01 |
| 2021 | $0.02 | −$0.14 | — | $0.01 | — | $0.01 |
| 2022 | $0.01 | −$0.26 | — | −$0.00 | — | $0.01 |
| 2023 | $0.00 | −$0.15 | — | −$0.00 | — | −$0.00 |
| 2024 | $0.00 | −$0.00 | — | −$0.00 | — | −$0.00 |
| 2025 | $0.00 | −$0.00 | — | −$0.00 | — | −$0.01 |